Drugs / BioLexa
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04544943 | May 2021 → Sep 2022 | atopic eczema | Hoth Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BioLexa | “twice daily application of topical BioLexa™ lotion, administered for 14 days in adult healthy subjects” NCT04544943 ↗ |
| Route | Topical | “Route of Administration: Topical; Dosage Form: Topical lotion.” NCT04544943 ↗ |